Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Liver
|
December 1, 1983
Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis
C Degott, F Degos, P Jungers, et al.
Lancet (London, England)
|
May 17, 1986
Hepatitis B vaccines with pre-S gene product
P Berthelot, R Neurath, A M Courouce, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1989
Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects
J J Lefrere, A M Courouce, P Lambin, et al.
AIDS (London, England)
|
February 1, 1988
Sedimentation rate as a predictive marker in HIV infection
J J Lefrère, D Salmon, C Doinel, et al.
Clinical Nephrology
|
September 1, 1977
Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study
D Kleinknecht, A M Courouce, S Delons, et al.
Lancet (London, England)
|
March 19, 1983
Long-lasting abatement of HBsAg synthesis induced by acute delta infection
D Frommel, J P Allain, A M Courouce, et al.
Presse Medicale (Paris, France : 1983)
|
November 23, 1985
[Vascular purpura caused by human parvoviruses]
J J Lefrere, A M Courouce, B Bigorie, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine
|
October 1, 1990
[Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?]
A M Jullien, A M Courouce, M Maniez, et al.
Clinical Chemistry
|
September 1, 1987
Monoclonal gammopathies in asymptomatic HIV-seropositive patients
J J Lefrere, J M Fine, P Lambin, et al.
Scandinavian Journal of Haematology. Supplementum
|
January 1, 1984
Use of HBV vaccine in hemophiliacs
C Gazengel, A M Courouce, M F Torchet, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Liver
|
December 1, 1983
Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis
C Degott, F Degos, P Jungers, et al.
Lancet (London, England)
|
May 17, 1986
Hepatitis B vaccines with pre-S gene product
P Berthelot, R Neurath, A M Courouce, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1989
Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects
J J Lefrere, A M Courouce, P Lambin, et al.
AIDS (London, England)
|
February 1, 1988
Sedimentation rate as a predictive marker in HIV infection
J J Lefrère, D Salmon, C Doinel, et al.
Clinical Nephrology
|
September 1, 1977
Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study
D Kleinknecht, A M Courouce, S Delons, et al.
Lancet (London, England)
|
March 19, 1983
Long-lasting abatement of HBsAg synthesis induced by acute delta infection
D Frommel, J P Allain, A M Courouce, et al.
Presse Medicale (Paris, France : 1983)
|
November 23, 1985
[Vascular purpura caused by human parvoviruses]
J J Lefrere, A M Courouce, B Bigorie, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine
|
October 1, 1990
[Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?]
A M Jullien, A M Courouce, M Maniez, et al.
Clinical Chemistry
|
September 1, 1987
Monoclonal gammopathies in asymptomatic HIV-seropositive patients
J J Lefrere, J M Fine, P Lambin, et al.
Scandinavian Journal of Haematology. Supplementum
|
January 1, 1984
Use of HBV vaccine in hemophiliacs
C Gazengel, A M Courouce, M F Torchet, et al.
Page
of 11